COVID-19–associated Pulmonary Aspergillosis | American Journal of Respiratory and Critical
Care Medicine ATS Journals Logo Official Publications of the American Thoracic Society Sign In …

The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in
healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is …

The devastating pandemia of the novel Coronavirus Disease 2019 (COVID-19) resulting
from the emergence of SARS-CoV-2 is of particular concern because of the development of …

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Our report of two critically ill patients suggests that IPA might be a relevant complication of
severe COVID-19 pneumonia in analogy to experiences in severe influenza pneumonia …

ABSTRACT COVID-19-associated pulmonary aspergillosis (CAPA) was recently reported as
a potential infective complication affecting critically ill patients with acute respiratory distress …

Objectives Patients with acute respiratory distress syndrome (ARDS) due to viral infection
are at risk for secondary complications like invasive aspergillosis. Our study evaluates …

Background Superinfections, including invasive pulmonary aspergillosis (IPA), are well-
known complications of critically ill patients with severe viral pneumonia. Aim of this study …

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …